The Institute will offer the patient the latest treatments as well as allow researchers and clinicians the opportunity to collaborate with cancer therapies, diagnosis and treatment plans. The facility will be housed in temporary quarters until a permanent building is created. With the multi collaborating efforts and easier availability of resources to cancer patients the facility should also be able to cut down the amount of time spent by patients in going to see various physicians as well as surgical procedures. BD
UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers. The Institute of Urologic Oncology at UCLA challenges the traditional model of academic departments operating independently of each other, bringing a multi-disciplinary team of scientists and physicians together as part of one cohesive organization. Their goal is to expedite the development of new therapies for patients with genitourinary cancers.
"This is a one-stop shop for patients. All the experts will be involved in their care, all working together," said Dr. Arie Belldegrun, a professor of urology, a researcher at UCLA's Jonsson Comprehensive Cancer Center and director of the new Institute of Urologic Oncology at UCLA. "Our goal is to bring all our resources to the patient, rather than the patient going from office to office to see everyone they need to see."
0 comments :
Post a Comment